Metformin+ Drospirenone/ethinylestradiol30µg and Flow-mediated Dilation in Polycystic Ovary Syndrome
Status:
Unknown status
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effects of ethinylestradiol 30µg-drospirenone
combined with metformin and weight loss by means of dietary intervention on the indices of
endothelial dysfunction (i.e. flow-mediated dilation and serum endothelin-1), serum
hsCRP,lipids,insulin resistance and body composition in young women with PCOS.
Phase:
N/A
Details
Lead Sponsor:
Iuliu Hatieganu University of Medicine and Pharmacy
Treatments:
Drospirenone Drospirenone and ethinyl estradiol combination Ethinyl Estradiol Metformin